Immunome, Inc. · NASDAQ:IMNM

Siegall Clay B received 180,000 Immunome, Inc. shares as an award (Form 4)

Traded Jul 23, 2026 · Filed Jul 27, 2026

On Jul 23, 2026, Siegall Clay B (Director, President and CEO) received 180,000 Immunome, Inc. shares as an award, leaving 870,704 shares. Filed Jul 27, 2026 (Form 4).

Awarded
180,000 shares
Holding after
870,704 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 23, 2026Common StockAward180,000870,704Direct

Source

View original at SEC

Related